Relay Therapeutics Correlations
| RLAY Stock | USD 7.14 0.20 2.72% |
The current 90-days correlation between Relay Therapeutics and Upstream Bio, is 0.38 (i.e., Weak diversification). The correlation of Relay Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Relay Therapeutics Correlation With Market
Weak diversification
The correlation between Relay Therapeutics and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Relay Stock
| 0.67 | PANACEABIO | Panacea Biotec | PairCorr |
| 0.88 | RAC | Race Oncology | PairCorr |
| 0.77 | VANI | Vivani Medical | PairCorr |
| 0.64 | DNLI | Denali Therapeutics | PairCorr |
| 0.63 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.82 | VCYT | Veracyte | PairCorr |
| 0.91 | VERA | Vera Therapeutics Earnings Call This Week | PairCorr |
| 0.87 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.73 | DRTS | Alpha Tau Medical | PairCorr |
| 0.82 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.63 | DSGN | Design Therapeutics Earnings Call This Week | PairCorr |
| 0.62 | DXB | Dimerix | PairCorr |
| 0.9 | DTIL | Precision BioSciences Downward Rally | PairCorr |
| 0.7 | DWTX | Dogwood Therapeutics, | PairCorr |
| 0.74 | DYAI | Dyadic International | PairCorr |
| 0.8 | VNDA | Vanda Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.94 | VRDN | Viridian Therapeutics Sell-off Trend | PairCorr |
Moving against Relay Stock
| 0.9 | DRMA | Dermata Therapeutics | PairCorr |
| 0.34 | AVH | Avita Medical Earnings Call This Week | PairCorr |
| 0.67 | SRZNW | Surrozen Warrant | PairCorr |
| 0.89 | VPRO | Viropro | PairCorr |
| 0.84 | 300238 | Guanhao Biotech | PairCorr |
| 0.58 | VXRT | Vaxart Inc | PairCorr |
| 0.57 | KTTAW | Pasithea Therapeutics | PairCorr |
| 0.53 | VRAX | Virax Biolabs Group | PairCorr |
Related Correlations Analysis
Risk-Adjusted Indicators
There is a big difference between Relay Stock performing well and Relay Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Relay Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| UPB | 3.62 | 0.85 | 0.21 | 2.01 | 3.16 | 8.48 | 25.94 | |||
| SEPN | 2.63 | 0.78 | 0.31 | 2.39 | 1.91 | 6.19 | 19.14 | |||
| PRME | 5.59 | 0.28 | 0.10 | 0.19 | 5.04 | 13.39 | 28.87 | |||
| NKTR | 3.91 | 1.63 | 0.49 | 1.09 | 2.45 | 10.33 | 33.83 | |||
| ZBIO | 5.32 | 1.01 | 0.20 | 0.46 | 5.21 | 9.50 | 40.28 | |||
| BCAX | 3.47 | 0.50 | 0.14 | 0.40 | 3.57 | 8.67 | 29.35 | |||
| PRAX | 7.32 | 3.75 | 0.77 | (0.74) | 2.87 | 9.20 | 191.57 | |||
| OCS | 1.50 | 0.14 | 0.02 | 2.46 | 2.06 | 4.89 | 13.45 | |||
| TNGX | 3.45 | 0.38 | 0.11 | 0.36 | 3.59 | 7.77 | 31.68 | |||
| XNCR | 3.27 | 0.70 | 0.23 | 0.39 | 3.09 | 10.71 | 24.00 |
Relay Therapeutics Corporate Management
| Deborah Palestrant | Vice Strategy | Profile | |
| SooYeun Lim | Senior Counsel | Profile | |
| MA MBA | Pres CEO | Profile | |
| Thomas Catinazzo | Chief Officer | Profile | |
| Iain Martin | Senior Development | Profile | |
| Andy Porter | Chief Officer | Profile |